J. Kell Williams, MD

home / authors / j-kell-williams-md

Articles

A New Contraceptive Option: A Focus on the Transdermal Contraceptive System

Andrew M. Kaunitz, MD;Ronald T. Burkman, MD;Sandra Ann Carson, MD;Paula J. Hillard, MD;J. Kell Williams, MD

November 15th 2011

And my task for this afternoon is to review for you a new contraceptive option and what I’d like to do first is show you my disclosure statement and then I will go into the first part of discussion, talk about why I think there’s a need for this new contraception option and then go in much greater depth in discussing it.

Transdermal Contraception: Contraception Patch. Interview with Ronald T. Burkman, MD

Andrew M. Kaunitz, MD;Ronald T. Burkman, MD;Sandra Ann Carson, MD;Paula J. Hillard, MD;J. Kell Williams, MD;Hans van der Slikke, MD, PhD

November 15th 2011

“We just heard a presentation about one of the several new devices for contraception and you took part in a lot of research about this Transdermal Patches for contraception.

A New Contraceptive Option: A Focus on the Transdermal Contraceptive System

Andrew M. Kaunitz, MD;Ronald T. Burkman, MD;Sandra Ann Carson, MD;Paula J. Hillard, MD;J. Kell Williams, MD

August 3rd 2011

A New Contraceptive Option: A Focus on the Transdermal Contraceptive System Ronald T. Burkman, MD Baystate Medical Center Tufts University School of Medicine

A New Contraceptive Option: A Focus on the Transdermal Contraceptive System

Andrew M. Kaunitz, MD;Ronald T. Burkman, MD;Sandra Ann Carson, MD;Paula J. Hillard, MD;J. Kell Williams, MD

August 3rd 2011

Tailoring HRT to Your Patients: An Expert Roundtable Discussion on the Issue

Andrew M. Kaunitz, MD;Andrew M. Kaunitz, MD;Ronald T. Burkman, MD;Sandra Ann Carson, MD;Paula J. Hillard, MD;J. Kell Williams, MD

July 29th 2011

The topic of hormone replacement therapy (HRT) continues to emerge as a central theme that we, as clinicians to female patients, address every day. We recognize that the public is much more aware of and interested in HRT now than was the case a decade ago.

Transitional Management: The Use of Oral Contraceptives in Perimenopause

July 12th 2011

A number of perimenopausal women and their health care providers choose to either decline or prematurely discontinue use of oral contraceptives (OCs), despite the availability of formulations that can prevent pregnancy and address perimenopausal symptoms. This lack of use is due to several factors.